CAI
Caris Life Sciences, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +30.0% ·
aandelenstroom +30.0% ·
netto nieuwe posities +20.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 91 | +10 | 93.54M | $1.67B | +15 | −5 |
| Q1 2026 | 83 | +5 | 87.87M | $1.57B | +14 | −10 |
| Q4 2025 | 79 | -1 | 69.03M | $1.86B | +2 | −2 |
| Q3 2025 | 18 | 0 | 36.49M | $1.10B | +3 | −4 |
| Q2 2025 | 16 | +13 | 32.21M | $860.64M | +13 | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Coatue Management ✦ | 10.14M | Nieuw | $271.00M | 0.8% | New | 1 | SEC ↗ |
| 2 | Coatue Management ✦ | 10.14M | Nieuw | $271.00M | 0.8% | New | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 8.63M | — | $230.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 8.63M | — | $230.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 8.63M | — | $230.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 8.63M | — | $230.63M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 6.76M | Nieuw | $180.65M | 0.0% | New | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 3.51M | Nieuw | $93.87M | 0.1% | New | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 999.95K | Nieuw | $26.72M | 0.0% | New | 1 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 458.48K | Nieuw | $12.25M | 0.0% | New | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (passief) | 375.00K | Nieuw | $10.02M | 0.0% | New | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 341.57K | Nieuw | $9.13M | 0.0% | New | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 341.57K | Nieuw | $9.13M | 0.0% | New | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 309.10K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passief) | 235.23K | Nieuw | $6.29M | 0.0% | New | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 150.00K | — | $4.01M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 150.00K | Nieuw | $4.01M | 0.0% | New | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passief) | 150.00K | — | $4.01M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 150.00K | — | $4.01M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Soros Fund Management ✦ | 50.00K | Nieuw | $1.34M | 0.0% | New | 1 | SEC ↗ |
| 29 | ARK Investment Management ✦ | 47.05K | Nieuw | $1.26M | 0.0% | New | 1 | SEC ↗ |
| 30 | Marshall Wace ✦ | 37.87K | Nieuw | $1.01M | 0.0% | New | 1 | SEC ↗ |
| 31 | Marshall Wace ✦ | 37.87K | Nieuw | $1.01M | 0.0% | New | 1 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 7.50K | Nieuw | $200,400 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Coatue Management | $271.00M | 0.8% |
| Coatue Management | $271.00M | 0.8% |
| T. Rowe Price | $180.65M | 0.0% |
| Millennium Management | $93.87M | 0.1% |
| Capital World Investors | $26.72M | 0.0% |
| Point72 Asset Management | $12.25M | 0.0% |
| Norges Bank | $10.02M | 0.0% |
| Citadel Advisors | $9.13M | 0.0% |
| Citadel Advisors | $9.13M | 0.0% |
| Geode Capital Management | $6.29M | 0.0% |
| Adage Capital Partners | $4.01M | 0.0% |
| Soros Fund Management | $1.34M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 200 houders, 153.41M aandelen, $2.53B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.